Anal fissure – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 05 Jun 2026 10:53:45 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Anal fissure – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on Treating Chronic Anal Fissure in Patients Using Ultrasound-Guided Injections of Botulinum Toxin A https://clinicaltrials.eu/trial/study-on-treating-chronic-anal-fissure-in-patients-using-ultrasound-guided-injections-of-botulinum-toxin-a/ Wed, 27 May 2026 09:46:29 +0000 https://clinicaltrials.eu/trial/study-on-treating-chronic-anal-fissure-in-patients-using-ultrasound-guided-injections-of-botulinum-toxin-a/ This clinical trial is focused on the treatment of chronic anal fissure, a condition characterized by a long-lasting tear in the lining of the anus, which can cause pain and discomfort. The study will use a treatment involving Botulinum Toxin Type A, a substance commonly known for its ability to relax muscles. In this trial, the Botulinum Toxin Type A will be administered as a powder that is mixed into a solution for injection.

The purpose of the study is to determine if using an ultrasound-guided technique to inject the Botulinum Toxin Type A is more effective and safer than the standard method. The ultrasound guidance helps in precisely locating the injection site, potentially improving the treatment’s effectiveness and safety. The study aims to establish a new technique that complements the existing one, making it more precise without increasing risks.

Participants in the study will receive injections of Botulinum Toxin Type A, and their progress will be monitored over a period of time. The study will assess the effectiveness of the treatment by measuring pain levels and any changes in symptoms. The goal is to see if this new method of injection can provide better relief for those suffering from chronic anal fissures.

]]>